These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis. Bartsch U, Galliciotti G, Jofre GF, Jankowiak W, Hagel C, Braulke T. Invest Ophthalmol Vis Sci; 2013 Oct 23; 54(10):6952-9. PubMed ID: 24084090 [Abstract] [Full Text] [Related]
26. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Pontikis CC, Cella CV, Parihar N, Lim MJ, Chakrabarti S, Mitchison HM, Mobley WC, Rezaie P, Pearce DA, Cooper JD. Brain Res; 2004 Oct 15; 1023(2):231-42. PubMed ID: 15374749 [Abstract] [Full Text] [Related]
30. Lymphocyte inclusions in Finnish-variant late infantile neuronal ceroid lipofuscinosis (CLN5). Rapola J, Lake BD. Neuropediatrics; 2000 Feb 15; 31(1):33-4. PubMed ID: 10774993 [Abstract] [Full Text] [Related]
31. Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis. Griffey M, Bible E, Vogler C, Levy B, Gupta P, Cooper J, Sands MS. Neurobiol Dis; 2004 Jul 15; 16(2):360-9. PubMed ID: 15193292 [Abstract] [Full Text] [Related]
32. [Juvenile neuronal ceroid-lipofusoinosis (Batten's disease). A new case with ultrastructural examination of the skin and lymphocytes]. Beauvais P, Arsenio-Nunes ML, Boccon-Gibod L, Brissaud HE. Ann Pediatr (Paris); 1978 Dec 15; 25(10):543-53. PubMed ID: 16114142 [No Abstract] [Full Text] [Related]
33. Topographic variabilities of immunoreactivity to subunit c of mitochondrial ATP synthase and lectin binding in late infantile neuronal ceroid-lipofuscinosis. Kida E, Wisniewski KE, Connell F. Am J Med Genet; 1995 Jun 05; 57(2):182-6. PubMed ID: 7668327 [Abstract] [Full Text] [Related]
37. A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging. Kopra O, Vesa J, von Schantz C, Manninen T, Minye H, Fabritius AL, Rapola J, van Diggelen OP, Saarela J, Jalanko A, Peltonen L. Hum Mol Genet; 2004 Dec 01; 13(23):2893-906. PubMed ID: 15459177 [Abstract] [Full Text] [Related]
38. Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9. Bronson RT, Donahue LR, Johnson KR, Tanner A, Lane PW, Faust JR. Am J Med Genet; 1998 May 26; 77(4):289-97. PubMed ID: 9600738 [Abstract] [Full Text] [Related]
39. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Ranta S, Zhang Y, Ross B, Lonka L, Takkunen E, Messer A, Sharp J, Wheeler R, Kusumi K, Mole S, Liu W, Soares MB, Bonaldo MF, Hirvasniemi A, de la Chapelle A, Gilliam TC, Lehesjoki AE. Nat Genet; 1999 Oct 26; 23(2):233-6. PubMed ID: 10508524 [Abstract] [Full Text] [Related]
40. Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice. Virmani T, Gupta P, Liu X, Kavalali ET, Hofmann SL. Neurobiol Dis; 2005 Nov 26; 20(2):314-23. PubMed ID: 16242638 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]